John Lewis
Vorstandsvorsitzender bei Nanostics, Inc.
Aktive Positionen von John Lewis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Nanostics, Inc.
 Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | Vorstandsvorsitzender | 01.01.2017 | - |
| Vorsitzender | 01.01.2017 | - | |
| Gründer | 01.01.2017 | - | |
Oisin Biotechnologies, Inc.
 Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA. | Technik-/Wissenschafts-/F&E-Leiter | 25.02.2014 | - |
| Gründer | 25.02.2014 | - | |
OncoSenx, Inc.
 OncoSenx, Inc. Pharmaceuticals: MajorHealth Technology Oncosenx, Inc. engages in the development of transient gene therapies which are designed for solid tumors. The company was founded in 2017 by Matthew Scholz, John D. Lewis, Gary C.Hudson and Eric Garcia and is headquartered in Seattle, WA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| Gründer | - | - | |
Entos Pharmaceuticals, Inc.
 Entos Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Entos Pharmaceuticals, Inc. develops nucleic acid-based therapies. The company was founded by John D. Lewis, Andries Zijlstra and Roy Duncan and is headquartered in Edmonton, Canada. | Vorstandsvorsitzender | - | - |
| Gründer | - | - |
Karriereverlauf von John Lewis
Statistik
International
| Kanada | 3 |
| Vereinigte Staaten | 3 |
Operativ
| Founder | 4 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sektoral
| Health Technology | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Nanostics, Inc.
Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | Health Technology |
Oisin Biotechnologies, Inc.
Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA. | Health Technology |
OncoSenx, Inc.
OncoSenx, Inc. Pharmaceuticals: MajorHealth Technology Oncosenx, Inc. engages in the development of transient gene therapies which are designed for solid tumors. The company was founded in 2017 by Matthew Scholz, John D. Lewis, Gary C.Hudson and Eric Garcia and is headquartered in Seattle, WA. | Health Technology |
Entos Pharmaceuticals, Inc.
Entos Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Entos Pharmaceuticals, Inc. develops nucleic acid-based therapies. The company was founded by John D. Lewis, Andries Zijlstra and Roy Duncan and is headquartered in Edmonton, Canada. | Commercial Services |
- Börse
- Insiders
- John Lewis
- Erfahrung
